Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

Abstract Background Second line anti-tuberculosis drugs are substantially complex, long term, more costly, and more toxic than first line anti-tuberculosis drugs. In Ethiopia, evidence on the incidence and predictors of adverse drug events has been limited. Thus, this study aimed at assessing incide...

Full description

Bibliographic Details
Main Authors: Mehari Woldemariam Merid, Lemma Derseh Gezie, Getahun Molla Kassa, Atalay Goshu Muluneh, Temesgen Yihunie Akalu, Melaku Kindie Yenit
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Infectious Diseases
Subjects:
Adverse drug event
Drug resistant tuberculosis
Second-line anti-tuberculosis drugs
Online Access:http://link.springer.com/article/10.1186/s12879-019-3919-1

Internet

http://link.springer.com/article/10.1186/s12879-019-3919-1

Similar Items